Clinical Trial Update: NAD Augmentation in Diabetes Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating NAD augmentation for diabetic kidney disease in adults with type 2 diabetes; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type2diabetes, Diabetic Kidney Disease | Phase 2 | Status: RECRUITING